GeneDx Holdings (WGS) Profit After Tax (2020 - 2026)

GeneDx Holdings (WGS) has reported Profit After Tax for 7 consecutive years, with -$63.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Profit After Tax fell 884.96% year-over-year to -$63.6 million; the TTM figure through Mar 2026 stood at -$78.2 million (down 103.7% YoY), while the FY2025 annual figure was -$21.0 million, up 59.8% from the prior year.
• Profit After Tax retreated to -$63.6 million in Q1 2026 per WGS's latest filing, from -$17.7 million in the prior quarter.
• Across five years, Profit After Tax topped out at $10.7 million in Q2 2025 and bottomed at -$308.8 million in Q4 2022.
• Historically, Profit After Tax has averaged -$50.7 million across 5 years, with a median of -$29.0 million in 2024.
• Annual changes were most pronounced in 2025 — Profit After Tax surged 136.95% — and 2026, when it sank 884.96%.
• GeneDx Holdings' Profit After Tax stood at -$308.8 million in 2022, then jumped by 91.79% to -$25.3 million in 2023, then soared by 119.51% to $4.9 million in 2024, then sank by 457.25% to -$17.7 million in 2025, then tumbled by 259.84% to -$63.6 million in 2026.
• Business Quant data shows WGS's Profit After Tax at -$63.6 million in Q1 2026, -$17.7 million in Q4 2025, and -$7.6 million in Q3 2025.